Stock IdeasStrong Buy StocksStrong Buy Stocks from Top Wall Street AnalystsLatest stocks with a Strong Buy rating from the top performing 25% of analysts tracked by WallStreetZen
Stock IdeasStrong Buy Stocks
| Analyst / Firm | Company | Price | Rating | Price Target | Upside/Downside | Date |
|---|---|---|---|---|---|---|
Grail IncGRAL | $143.26 | Strong Buy | $175.00 | +22.16% | 19 hours ago | |
Analyst RankingTop 10% #552 out of 5530 analysts Average Return+29.82% Win Rate52%29 out of 56 Risk vs RewardPoor Good Analyst ColorUBS's Doug Schenkel raised their price target on Grail (NASDAQ: GRAL) by 66.7% from $105 to $175 on 2026/10/02. The analyst maintained their Strong Buy rating on the stock. After reviewing FDA panel results and CMS checks, Schenkel said they are more convinced than ever that Grail will get FDA clearance in early 2027 and eventually earn payment from CMS. Regardless of the precise labeling, the analyst expects reimbursement to be supported by recent legislation upon FDA clearance. | ||||||
Tesla IncTSLA | $800.00 | Strong Buy | $850.00 | +6.25% | 2 days ago | |
Upgrade to Premium to View MoreStrong buys: Upgrade to Premium to view the rest of today's Strong Buy stocks from Wall Street's top analysts Already have access to Premium? Sign In | ||||||
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.